von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome.
Hemolytic uremic syndrome (HUS) usually occurs after infection with Shiga toxin-producing bacteria. Thrombotic thrombocytopenic purpura, a disorder with similar clinical manifestations, is associated with deficient activity of a circulating metalloprotease that cleaves von Willebrand factor at the Tyr842-Met843 peptide bond in a shear stress-dependent manner. We analyzed von Willebrand factor-cleaving metalloprotease activity and the status of von Willebrand factor in 16 children who developed HUS after Escherichia coli O157:H7 infection and in 29 infected children who did not develop this complication. Von Willebrand factor-cleaving metalloprotease activity was normal in all subjects, but von Willebrand factor size was decreased in the plasma of each of 16 patients with HUS. The decrease in circulating von Willebrand factor size correlated with the severity of thrombocytopenia and was proportional to an increase in von Willebrand factor proteolytic fragments in plasma. Immunohistochemical studies of the kidneys in four additional patients who died of HUS demonstrated glomerular thrombi in three patients, and arterial and arteriolar thrombi in one patient. The glomerular thrombi contained fibrin but little or no von Willebrand factor. A decrease in large von Willebrand factor multimers, presumably caused by enhanced proteolysis from abnormal shear stress in the microcirculation, is common in HUS.
Tsai
H M
HM
Montefiore Medical Center/Albert Einstein College of Medicine, Division of Hematology, Bronx, NY 10467, USA. htsai@montefiore.org
Chandler
W L
WL
Sarode
R
R
Hoffman
R
R
Jelacic
S
S
Habeeb
R L
RL
Watkins
S L
SL
Wong
C S
CS
Williams
G D
GD
Tarr
P I
PI
D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; D002648:Child; D002675:Child, Preschool; D004927:Escherichia coli Infections / Q000097:blood* / Q000201:enzymology; D019453:Escherichia coli O157 / Q000302:isolation & purification*; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000097:blood* / Q000201:enzymology / Q000382:microbiology; D006801:Humans; D006868:Hydrolysis; D007150:Immunohistochemistry; D007668:Kidney / Q000473:pathology; D008297:Male; D008666:Metalloendopeptidases / Q000097:blood*; D014841:von Willebrand Factor / Q000378:metabolism*
D014841:von Willebrand Factor; D051722:ADAM Proteins; D008666:Metalloendopeptidases; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human